65,437 trials
Overactive Bladder Syndrome (OABS)
Primary: Change From Baseline to Week 8 in the Number of Voids/24 Hours — -1.06; -1.44; -1.78; -2.41 voids/24 hrs.
Diabetes Mellitus Type 2
Primary: Change From Baseline in Glycosylated Hemoglobin (HbA1c) in Overweight and Obese Participants With Type 2 Diabetes Mellitus — -1.52; -1.29; -1.28; -0.27 percentage of…
Epilepsy
Primary: Cmax BIA 2-005 - the Maximum Plasma Concentration of BIA 2-005 — 7107.7; 10724.8; 13186.4; 6660.3 ng/mL
Pulmonary Hypertension, Persistent, of the Newborn
Primary: Number of Participants With Physical Examination Abnormalities at Month 12 — 0 participants
Asthma
Primary: Average Number of Coughs Per Hour — 57.64; .63 average number of coughs per hour
Pain · Delayed Onset Muscle Soreness
Primary: Mean Reduction in SPID Scores of DOMS on Walking Over 24 Hours — 34.87; 23.62 units on a scale — p=0.0324
Hyperphosphatemia · Kidney Failure
Primary: Change in Mean Serum Phosphorus From Baseline (Week 52) to the End of the Efficacy Assessment Period (EAP; Week 56) — 5.44; 5.12; 7.23; 4.89 mg/dL — p=<0.0001
Atopic Dermatitis
Primary: Change in Percentage of Body Involvement — -2.0; 0.15 Change of percentage in body involvement
Carcinoma of Unknown Primary
Primary: Progression Free Survival — 5.4; 5.3 months
Insomnia
Primary: Sleep Onset Latency (SOL) as Measured by Self Report (Sleep Diary) — 29.7; 24.8 minutes
Multiple Sclerosis
Primary: A Change in the Cumulative Number of Gd Enhancing Lesions Using a 3T Protocol. — -3.7; -3.6 GAD lesions (number of)
Psychotic Disorder
Primary: Verbal Acquisition — 22.8; 22.0; 22.7; 29.5 correctly encoded words — p=<0.01
Glaucoma
Primary: Intraocular Pressure — 10.7; 11.2 mmHg — p=.85
Meibomian Gland Dysfunction
Primary: Comfort as Measured by the Contact Lens Users Experience Questionnaire (CLUE) — 58.67 units on a scale
Hypoxic Ischemic Encephalopathy
Primary: Percentage of Temperatures in Target Range During Transport — 0; 73 Percentage of temperatures — p=<0.001